Fish oil has been touted as useful for everything from growing hair to treating clinical depression. Now drug makers are stepping up their promotion of its benefits for treating heart disease.
AstraZeneca Plc (AZN), Amarin Corp. (AMRN) and GlaxoSmithKline Plc (GSK) (GSK) are betting the market for prescription fish-oil pills will follow the success of cholesterol-lowering drugs including Lipitor, once the world’s best-selling medicine with revenue of $13 billion a year.
To read the original article: Fish-Oil Pills Lure Drugmakers Even as Benefits Unproven - Businessweek
